The effectiveness of chemotherapy in "real world" patients with metastatic bladder cancer

被引：2
|
作者：
Galsky, M. D. [1 ]
Pal, S. K. [2 ]
Lin, S. W. [3 ]
Ogale, S. [3 ]
Simpson, J. [3 ]
Schiff, C. [3 ]
Sonpavde, G. [4 ]
机构：
[1] Mt Sinai Hosp, Icahn Sch Med, New York, NY 10029 USA
[2] City Hope Comprehens Canc Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA USA
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31442-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2624
引用
收藏
页码：S520 / S521
页数：2
相关论文
共 50 条
  • [41] Real-world effectiveness of everolimus versus endocrine monotherapy or chemotherapy in HR+/HER2-metastatic breast cancer patients with liver metastasis or multiple metastatic sites
    Li, N.
    Hao, Y.
    Lin, P. L.
    Koo, V.
    Ohashi, E.
    Wu, E. Q.
    Xie, J.
    CANCER RESEARCH, 2016, 76
  • [42] Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer
    Herr, HW
    Donat, SM
    Bajorin, DF
    JOURNAL OF UROLOGY, 2001, 165 (03): : 811 - 814
  • [43] Gender disparities in chemotherapy use and survival in patients with metastatic bladder cancer (BCa).
    Rose, Tracy Lynn
    Deal, Allison Mary
    Yang, Hojin
    Nielsen, Matthew Edward
    Smith, Angela
    Milowsky, Matthew I.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] Real-world effectiveness of fulvestrant monotherapy as first hormonal therapy in metastatic breast cancer patients.
    Olufade, Temitope O.
    Skinner, Karen E.
    Di Santo, Nicola
    Shenolikar, Rahul A.
    Walker, Mark Stephen
    Schwartzberg, Lee Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer
    Rugo, Hope S.
    Liu, Xianchen
    Li, Benjamin
    McRoy, Lynn
    Chen, Connie
    Layman, Rachel M.
    Brufsky, Adam
    ONCOLOGIST, 2023, 28 (10): : 866 - 874
  • [46] Palbociclib plus aromatase inhibitors in patients with metastatic breast cancer and cardiovascular diseases: real-world effectiveness
    Brufsky, Adam
    Liu, Xianchen
    Li, Benjamin
    McRoy, Lynn
    Chen, Connie
    Makari, Doris
    Layman, Rachel M.
    Rugo, Hope S.
    ONCOLOGIST, 2024, 29 (12): : 1032 - 1043
  • [47] Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in Canada
    Cheung, Winson Y.
    Samimi, Setareh
    Ma, Kim
    Knight, Gregory John
    Kassam, Shaqil
    Colwell, Bruce
    Beaudoin, Annie
    Vincent, Mark David
    Trinkaus, Mateya
    Filion, Alain
    Marquis, Katerine
    Karachiwala, Hatim
    Asmis, Timothy
    Sideris, Lucas
    Wani, Rajvi J.
    Ngan, Elaine
    Inam, Naila
    Du, Yinhao
    Nunez, Leyla
    Eberg, Maria
    Alemayehu, Mistre
    Meyer, Pierre-Francois
    Mancini, Johanna
    Morris, Carlye Cirone
    CLINICAL COLORECTAL CANCER, 2024, 23 (01) : 46 - 57.e4
  • [48] Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan
    Yeh, Kun-Huei
    Yang, Tsai-Sheng
    Hsu, Tzu-Chi
    Chen, William Tzu-Liang
    Chen, Hong-Hwa
    Teng, Hao-Wei
    Lin, Bo-Wen
    Kuan, Feng-Che
    Chiang, Feng-Fan
    Duann, Chi-Wei
    Li, Ying-Shiuan
    Lin, Meng-Ting
    Fiala-Buskies, Sabine
    Ducreux, Michel
    Wang, Jaw-Yuan
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (11) : 2023 - 2031
  • [49] The REWRITE Study-REal-WoRld effectIveness of TrifluridinE/tipiracil in Patients with Previously Treated Metastatic Colorectal Cancer
    Marques, D.
    Costa, A. L.
    Mansinho, A.
    Quintela, A.
    Pratas, E.
    Brito-da-Silva, J.
    Cruz, J.
    Felix, J.
    Rodrigues, J.
    Mota, M.
    Teixeira, A. R.
    Damaso, S.
    Pinheiro, S.
    Andreozzi, V.
    Costa, L.
    Barros, A. G.
    CLINICAL ONCOLOGY, 2023, 35 (10) : 665 - 672
  • [50] "Real world" effectiveness of different postoperative adjuvant chemotherapy regimens in stage III colon cancer patients.
    Chiang, Jy Ming
    Hung, Hsin Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
12345